STVN - Stevanato Group S.p.A.
NYSE
->
Healthcare
->
Medical Instruments & Supplies
Piombino Dese,
Italy
Type: Equity
STVN price evolution
STVN
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $78.15 | $186.33 | $69.6 | |
| Short term investments | $2.32 | $3.33 | $4.38 | |
| Net receivables | $496.29 | $293.47 | $271.93 | $345.67 |
| Inventory | $286.59 | $302.78 | $283.09 | $255.32 |
| Total current assets | $863.52 | $869.69 | $939.79 | $861.89 |
| Long term investments | $0.38 | $0.68 | $0.68 | |
| Property, plant & equipment | $1174.5 | $1156.34 | $1107.41 | $1046.74 |
| Goodwill & intangible assets | $82.18 | $81.03 | $80.97 | |
| Total noncurrent assets | $1327.36 | $1272.95 | $1209.68 | |
| Total investments | $2.7 | $4 | $5.06 | |
| Total assets | $2213.84 | $2197.05 | $2212.74 | $2071.58 |
| Current liabilities | ||||
| Accounts payable | $246.15 | $256.94 | $239.38 | $277.81 |
| Deferred revenue | $23.5 | $25.77 | $22.31 | |
| Short long term debt | $66.58 | $96.23 | $143.28 | |
| Total current liabilities | $477.06 | $499.56 | $488.21 | $574.39 |
| Long term debt | $288.66 | $252.37 | $280.54 | $255.64 |
| Total noncurrent liabilities | $373.27 | $394.1 | $364.54 | |
| Total debt | $318.95 | $376.77 | $398.92 | |
| Total liabilities | $891.6 | $872.83 | $882.31 | $938.93 |
| Shareholders' equity | ||||
| Retained earnings | $1300.02 | $1262.49 | $1289.32 | $965.2 |
| Other shareholder equity | ||||
| Total shareholder equity | $1324.17 | $1330.37 | $1132.53 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $69.6 | $228.74 | $411.04 | $115.6 |
| Short term investments | $4.38 | $33.6 | $27.22 | $41.54 |
| Net receivables | $345.67 | $245.74 | $191.6 | $131.8 |
| Inventory | $255.32 | $213.25 | $148.92 | $139.37 |
| Total current assets | $861.89 | $845.77 | $865.97 | $492.77 |
| Long term investments | $0.68 | $0.78 | $1.08 | $2.77 |
| Property, plant & equipment | $1046.74 | $660.69 | $415.41 | $339.04 |
| Goodwill & intangible assets | $80.97 | $79.4 | $79.17 | $81.14 |
| Total noncurrent assets | $1209.68 | $813.92 | $552.87 | $475.2 |
| Total investments | $5.06 | $34.38 | $28.3 | $44.31 |
| Total assets | $2071.58 | $1659.7 | $1418.84 | $967.98 |
| Current liabilities | ||||
| Accounts payable | $277.81 | $239.18 | $164.79 | $118.74 |
| Deferred revenue | $22.31 | $14.85 | $18.77 | $5.03 |
| Short long term debt | $143.28 | $70.75 | $46.2 | $81.23 |
| Total current liabilities | $574.39 | $462.5 | $338.62 | $316.18 |
| Long term debt | $255.64 | $148.41 | $202.3 | $294.12 |
| Total noncurrent liabilities | $364.54 | $201.29 | $238.56 | $341.66 |
| Total debt | $398.92 | $219.16 | $248.49 | $375.36 |
| Total liabilities | $938.93 | $663.79 | $577.18 | $657.84 |
| Shareholders' equity | ||||
| Retained earnings | $965.2 | $831.58 | $686.05 | $211.98 |
| Other shareholder equity | $0 | |||
| Total shareholder equity | $1132.53 | $996.13 | $842.07 | $310.5 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $277.87 | $259.58 | $235.99 | $320.64 |
| Cost of revenue | $192.06 | $173.8 | $218.8 | |
| Gross Profit | $77.94 | $67.52 | $62.2 | $101.83 |
| Operating activities | ||||
| Research & development | $8.74 | $10.75 | $10.07 | |
| Selling, general & administrative | $31.75 | $27.5 | $30.71 | |
| Total operating expenses | $32.52 | $39.55 | $36.91 | $37.79 |
| Operating income | $27.97 | $25.29 | $64.05 | |
| Income from continuing operations | ||||
| EBIT | $30.67 | $29.44 | $68.36 | |
| Income tax expense | $10.77 | $8.55 | $6.86 | $13.56 |
| Interest expense | -$0.15 | $1.49 | $3.76 | $9.56 |
| Net income | ||||
| Net income | $30.03 | $20.63 | $18.81 | $45.23 |
| Income (for common shares) | $20.63 | $18.81 | $45.23 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1085.35 | $983.68 | $843.92 | $662.04 |
| Cost of revenue | $745.46 | $663.88 | $578.51 | $467.86 |
| Gross Profit | $339.89 | $319.8 | $265.4 | $194.18 |
| Operating activities | ||||
| Research & development | $35.67 | $34.39 | $29.62 | $17.39 |
| Selling, general & administrative | $113.92 | $111.83 | $82.95 | $78.91 |
| Total operating expenses | $139.17 | $127.37 | $103.18 | $91.07 |
| Operating income | $200.72 | $192.43 | $162.22 | $103.11 |
| Income from continuing operations | ||||
| EBIT | $220.91 | $217.31 | $184.53 | $118.04 |
| Income tax expense | $43.86 | $44.63 | $31.4 | $17.68 |
| Interest expense | $31.42 | $29.84 | $18.81 | $21.85 |
| Net income | ||||
| Net income | $145.63 | $142.85 | $134.32 | $78.51 |
| Income (for common shares) | $145.63 | $142.85 | $134.32 | $78.51 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $20.63 | $18.81 | $45.23 | |
| Operating activities | ||||
| Depreciation | $20.85 | $21.66 | $20.06 | |
| Business acquisitions & disposals | -$0.17 | |||
| Stock-based compensation | ||||
| Total cash flows from operations | $22.25 | $71.59 | $10.19 | |
| Investing activities | ||||
| Capital expenditures | -$65.68 | -$100.53 | -$81.54 | |
| Investments | -$0.44 | $0.77 | -$2.03 | |
| Total cash flows from investing | -$219.18 | -$69.5 | -$102.11 | -$64.38 |
| Financing activities | ||||
| Dividends paid | -$14.46 | -$10.45 | ||
| Sale and purchase of stock | -$0.71 | $170.53 | ||
| Net borrowings | -$58.66 | -$23.67 | $98.19 | |
| Total cash flows from financing | $116.9 | -$59.37 | $146.86 | $59.83 |
| Effect of exchange rate | -$1.47 | -$1.57 | $0.39 | -$0.86 |
| Change in cash and equivalents | $8.39 | -$106.61 | $116.34 | $5.64 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $145.63 | $142.85 | $134.32 | $78.51 |
| Operating activities | ||||
| Depreciation | $78.48 | $64.82 | $56.38 | $54.1 |
| Business acquisitions & disposals | -$3.59 | $14.81 | ||
| Stock-based compensation | ||||
| Total cash flows from operations | $105.21 | $103.31 | $133.34 | $155.66 |
| Investing activities | ||||
| Capital expenditures | -$432.66 | -$234.88 | -$106.52 | -$89.55 |
| Investments | -$4.19 | $0.03 | $0.77 | -$0.1 |
| Total cash flows from investing | -$421.22 | -$242.95 | -$96.43 | -$96.09 |
| Financing activities | ||||
| Dividends paid | -$14.29 | -$13.5 | -$11.2 | -$8.9 |
| Sale and purchase of stock | $380.09 | |||
| Net borrowings | $172.57 | -$31.04 | -$128.4 | -$17.08 |
| Total cash flows from financing | $158.03 | -$44.54 | $254.85 | -$26.52 |
| Effect of exchange rate | -$1.16 | $1.88 | $3.68 | -$2.84 |
| Change in cash and equivalents | -$157.98 | -$184.17 | $291.76 | $33.05 |
News
Fundamentals
| Market cap | $5.48B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 272.90M |
| Revenue | $1.09B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $114.70M |
| Revenue Q/Q | 2.38% |
| Revenue Y/Y | 3.53% |
| P/E ratio | 47.80 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 5.01 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $0.42 |
|---|---|
| ROA | 5.28% |
| ROE | N/A |
| Debt/Equity | 0.83 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.81 |
| Quick ratio | 1.21 |